Cargando…
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://www.ncbi.nlm.nih.gov/pubmed/29947834 http://dx.doi.org/10.1007/s00059-018-4719-x |